Consainsights logo

Mrsa Testing Market Size, Share, Industry Trends and Forecast to 2030

Mrsa Testing Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Size & CAGR in 2021

The global MRSA testing market is expected to witness a significant growth rate with a CAGR of 5.2% from 2021 to 2028. This growth is anticipated to result in the market reaching a value of USD 1.5 billion by 2028. The increasing prevalence of MRSA infections and the rising awareness regarding the importance of early detection and treatment are driving the growth of the MRSA testing market.

COVID-19 Impact on the MRSA Testing Market

The COVID-19 pandemic has had a significant impact on the MRSA testing market. With healthcare systems across the globe focusing on managing the pandemic, the detection and treatment of MRSA infections have become more challenging. This has led to a temporary slowdown in the MRSA testing market. However, as healthcare systems adapt to the new normal and prioritize the management of other infectious diseases, the market is expected to recover and grow steadily post-pandemic.

MRSA Testing Dynamics

MRSA testing plays a crucial role in the early detection and management of MRSA infections, which are known to be resistant to common antibiotics. The market dynamics are driven by the increasing incidence of MRSA infections, the development of advanced testing technologies, and the growing investments in healthcare infrastructure. With the rise in hospital-acquired infections and the prevalence of community-acquired MRSA, the demand for MRSA testing is expected to rise significantly in the coming years.

Segments and Related Analysis

Types of MRSA Testing:

1. Molecular Diagnostics

2. Immunodiagnostic Testing

3. Culture Testing

By Application:

1. Hospitals

2. Diagnostic Laboratories

3. Others

By Region Analysis

North America:

North America is expected to dominate the MRSA testing market, owing to the high prevalence of MRSA infections and the presence of advanced healthcare infrastructure in the region. The increasing investments in research and development activities in the healthcare sector will further boost the market growth.

Europe:

Europe is anticipated to witness significant growth in the MRSA testing market, attributed to the rising awareness about MRSA infections and the implementation of stringent healthcare regulations. The increasing adoption of advanced diagnostic technologies in the region will drive market growth.

Asia Pacific:

The Asia Pacific region is projected to experience rapid growth in the MRSA testing market due to the increasing prevalence of MRSA infections and the rising investments in healthcare infrastructure. The growing awareness about the importance of early diagnosis and treatment of MRSA infections will drive market expansion in the region.

Key Market Players and Competitive Landscape

1. Becton Dickinson and Company

2. Roche Diagnostics

3. Thermo Fisher Scientific

4. Bio-Rad Laboratories

5. Alere Inc.

6. Cepheid

7. Abbott Laboratories

8. Danaher Corporation

9. Hologic, Inc.

Recent Happenings in the MRSA Testing Market

1. In May 2021, Becton Dickinson launched a new molecular diagnostic test for MRSA detection, aimed at improving the accuracy and speed of MRSA diagnosis.

2. Roche Diagnostics announced the development of a novel immunodiagnostic test for MRSA in September 2021, which is expected to revolutionize MRSA testing procedures.

3. Thermo Fisher Scientific introduced a state-of-the-art culture testing method for MRSA detection in January 2022, providing healthcare providers with more reliable results.

4. Bio-Rad Laboratories collaborated with leading research institutions to advance research on MRSA epidemiology and develop innovative testing solutions in March 2022.

5. Alere Inc. received FDA approval for its rapid MRSA diagnostic test in July 2022, paving the way for enhanced MRSA testing capabilities in healthcare settings.

Frequently Asked Questions (FAQ):